Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
- 1 May 2001
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 32 (2) , 179-187
- https://doi.org/10.1016/s0169-5002(00)00212-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter TrialJournal of Clinical Oncology, 2000
- Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trialCancer Chemotherapy and Pharmacology, 1999
- A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancerLung Cancer, 1994
- Second-line with vinorelbine in the weekly monochemotherapy for the treatment of advanced non small cell lung cancer (NSCLC)Lung Cancer, 1994
- Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991